B
Brian G. Czito
Researcher at Duke University
Publications - Â 200
Citations - Â 6945
Brian G. Czito is an academic researcher from Duke University. The author has contributed to research in topics: Radiation therapy & Colorectal cancer. The author has an hindex of 34, co-authored 195 publications receiving 5812 citations. Previous affiliations of Brian G. Czito include Siemens & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Pancreatic adenocarcinoma, version 2.2017: Clinical practice guidelines in Oncology
Margaret A. Tempero,Mokenge P. Malafa,Mahmoud M. Al-Hawary,Horacio J. Asbun,Andrew Bain,Stephen W. Behrman,Al B. Benson,Ellen F. Binder,Dana Backlund Cardin,Charles Cha,E. Gabriela Chiorean,Vincent Chung,Brian G. Czito,Mary Dillhoff,Efrat Dotan,Cristina R. Ferrone,Jeffrey M. Hardacre,William G. Hawkins,Joseph M. Herman,Andrew H. Ko,Srinadh Komanduri,Albert C. Koong,Noelle K. LoConte,Andrew M. Lowy,Cassadie Moravek,Eric K. Nakakura,Eileen M. O'Reilly,Jorge Obando,Sushanth Reddy,Courtney L. Scaife,Sarah P. Thayer,Colin D. Weekes,Robert A. Wolff,Brian M. Wolpin,Jennifer L. Burns,Susan Darlow +35 more
TL;DR: The NCCN Guidelines for Pancreatic Adenocarcinoma focus on diagnosis and treatment with systemic therapy, radiation therapy, and surgical resection, as well as on management of locally advanced unresectable and metastatic disease.
Journal ArticleDOI
Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012. (5)
Journal ArticleDOI
Efficacy, Safety, and Biomarkers of Neoadjuvant Bevacizumab, Radiation Therapy, and Fluorouracil in Rectal Cancer: A Multidisciplinary Phase II Study
Christopher G. Willett,Dan G. Duda,Emmanuelle di Tomaso,Yves Boucher,Marek Ancukiewicz,Dushyant V. Sahani,Johanna Lahdenranta,Daniel C. Chung,Alan J. Fischman,Gregory Y. Lauwers,Paul C. Shellito,Brian G. Czito,Terence Z. Wong,Erik K. Paulson,Martin Poleski,Zeljko Vujaskovic,Rex C. Bentley,Helen X. Chen,Jeffrey W. Clark,Rakesh K. Jain +19 more
TL;DR: Bvacizumab with chemoradiotherapy appears safe and active and yields promising survival results in locally advanced rectal cancer.
Journal ArticleDOI
Pancreatic adenocarcinoma, Version 2.2021
Margaret A. Tempero,Mokenge P. Malafa,Mahmoud M. Al-Hawary,Stephen W. Behrman,Al B. Benson,Dana Backlund Cardin,E. Gabriela Chiorean,Vincent Chung,Brian G. Czito,Marco Del Chiaro,Mary Dillhoff,Timothy R. Donahue,Efrat Dotan,Cristina R. Ferrone,Christos Fountzilas,Jeffrey M. Hardacre,William G. Hawkins,Kelsey Klute,Andrew H. Ko,John W. Kunstman,Noelle K. LoConte,Andrew M. Lowy,Cassadie Moravek,Eric K. Nakakura,Amol Narang,Jorge Obando,Patricio M. Polanco,Sushanth Reddy,Marsha Reyngold,Courtney L. Scaife,Jeanne Shen,Charles M. Vollmer,Robert A. Wolff,Brian M. Wolpin,Beth Lynn,Giby V. George +35 more
Abstract: Pancreatic cancer is the fourth leading cause of cancer-related death among men and women in the United States. A major challenge in treatment remains patients' advanced disease at diagnosis. The NCCN Guidelines for Pancreatic Adenocarcinoma provides recommendations for the diagnosis, evaluation, treatment, and follow-up for patients with pancreatic cancer. Although survival rates remain relatively unchanged, newer modalities of treatment, including targeted therapies, provide hope for improving patient outcomes. Sections of the manuscript have been updated to be concordant with the most recent update to the guidelines. This manuscript focuses on the available systemic therapy approaches, specifically the treatment options for locally advanced and metastatic disease.
Journal ArticleDOI
Pancreatic Adenocarcinoma, Version 2.2014
Margaret A. Tempero,Mokenge P. Malafa,Stephen W. Behrman,Al B. Benson,Ephraim S. Casper,E. Gabriela Chiorean,Vincent Chung,Steven J. Cohen,Brian G. Czito,Anitra Engebretson,Mary Feng,William G. Hawkins,Joseph M. Herman,John P. Hoffman,Andrew H. Ko,Srinadh Komanduri,Albert C. Koong,Andrew M. Lowy,Wen Wee Ma,Nipun B. Merchant,Sean J. Mulvihill,Peter Muscarella,Eric K. Nakakura,Jorge Obando,Martha B. Pitman,Sushanth Reddy,Aaron R. Sasson,Sarah P. Thayer,Colin D. Weekes,Robert A. Wolff,Brian M. Wolpin,Jennifer L. Burns,Deborah A. Freedman-Cass +32 more
TL;DR: These NCCN Guidelines Insights summarize major discussion points from the 2014 NCCn Pancreatic Adenocarcinoma Panel meeting, which focused mainly on the management of borderline resectable and locally advanced disease.